Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | EPM2A | O95278 | 1/20 | 0.31 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.31 |
| ▸ | PIM1 | P11309 | 1/20 | 0.31 |
| ▸ | GPR3 | P46089 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19862360 | 0.94 | ALOX5 (0.34) | ALOX5PDK2EPM2APTPN2PTPN1 | |
| SCHEMBL19395198 | 0.84 | PDK2 (0.42) | ALOX5PDK2EPM2APTPN2PTPN1 | |
| SCHEMBL19395200 | 0.84 | PDK2 (0.42) | ALOX5PDK2EPM2APTPN2PTPN1 | |
| SCHEMBL19760322 | 0.82 | ALOX5 (0.44) | ALOX5PDK2PTPN1PTPN22GPR3 | |
| SCHEMBL19862350 | 0.80 | HSP90AA1 (0.35) | ALOX5PDK2ALDH1A1MAPT | |
| SCHEMBL19863939 | 0.80 | PDK2 (0.39) | PDK2PIM1ALDH1A1POLBTDP1 | |
| SCHEMBL19869583 | 0.79 | PDK2 (0.38) | PDK2 | |
| SCHEMBL19395194 | 0.77 | PDK2 (0.42) | ALOX5PDK2PIM1GPR3ALDH1A1 | |
| SCHEMBL19395196 | 0.77 | PDK2 (0.42) | ALOX5PDK2PIM1GPR3ALDH1A1 | |
| SCHEMBL19862366 | 0.77 | ALOX5 (0.40) | ALOX5PDK2PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10454039-B2 | Compound and organic electronic device using the same | SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) | 2019-10-22 | — | — | US | disclosed |
| US-20180047918-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | NICHEM FINE TECHNOLOGY CO., LTD. (TW) | 2018-02-15 | — | — | US | disclosed |
| US-20180047918-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | NICHEM FINE TECHNOLOGY CO., LTD. (TW) | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180047918-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | ORC3, AOX1, RCOR3 | ALOX5 4218/4885PDK2 2964/4885EPM2A 3828/4885 |
| US-10454039-B2 | Compound and organic electronic device using the same | ORC3, AOX1, RCOR3 | ALOX5 4218/4885PDK2 2964/4885EPM2A 3828/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.